Insider Trading Summary for Agios Pharmaceuticals, Inc. (AGIO): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Jun-24 5:32 PM View:	13-Jun-24 Gift 0	Foster-Cheek Kaye I Director		Agios Pharmaceuticals, Inc. - AGIO	(45%) 13.72K to 7.55K	0	0	--	--	Show Txns Hide Txns

17-Jun-24 5:19 PM View:	13-Jun-24 Option Exercise 0	Ho Maykin Director		Agios Pharmaceuticals, Inc. - AGIO	29% 11.52K to 14.91K	0	0	--	--	Show Txns Hide Txns

17-Jun-24 5:18 PM View:	13-Jun-24 Option Exercise 0	Scadden David Director		Agios Pharmaceuticals, Inc. - AGIO	28% 12.1K to 15.48K	0	0	--	--	Show Txns Hide Txns

17-Jun-24 5:29 PM View:	13-Jun-24 Option Exercise 0	Schenkein David P Director		Agios Pharmaceuticals, Inc. - AGIO	1% 472.71K to 476.1K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:20 PM View:	05-Mar-24 Planned Option Sale ($86.05K)	Gheuens Sarah Chief Medical Officer		Agios Pharmaceuticals, Inc. - AGIO	58% 24.66K to 39.07K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:08 PM View:	05-Mar-24 Planned Option Sale ($86.05K)	Burns James William Chief Legal Officer		Agios Pharmaceuticals, Inc. - AGIO	53% 24.25K to 37.17K	0	0	--	--	Show Txns Hide Txns

05-Jun-24 4:14 PM View:	03-Jun-24 Market Sale ($60.46K)	Washburn Theodore James Jr. Principal Accounting Officer		Agios Pharmaceuticals, Inc. - AGIO	(44%) 2.74K to 1.52K	0	($60.46K) (50%)	--	$44.39	Show Txns Hide Txns

12-Aug-24 5:15 PM View:	08-Aug-24 Planned Option Sale ($474.14K)	Goff Brian Chief Executive Officer Director		Agios Pharmaceuticals, Inc. - AGIO	196% 26.59K to 78.79K	0	0	--	--	Show Txns Hide Txns

17-Jun-24 5:22 PM View:	13-Jun-24 Option Exercise 0	Ballal Rahul D. Director		Agios Pharmaceuticals, Inc. - AGIO	147% 2.3K to 5.69K	0	0	--	--	Show Txns Hide Txns

13-Aug-24 4:12 PM View:	11-Aug-24 Option Exercise 0	Smith Cynthia Director		Agios Pharmaceuticals, Inc. - AGIO	247% 2.3K to 7.99K	0	0	--	--	Show Txns Hide Txns

30-Sep-24 4:15 PM View:	26-Sep-24 Planned Option Sale ($124.63K)	Jones Cecilia Chief Financial Officer		Agios Pharmaceuticals, Inc. - AGIO	111% 9.57K to 20.16K	0	0	--	--	Show Txns Hide Txns

24-Jan-24 4:19 PM View:	24-Jan-24 Planned Option Sale ($35.01K)	Milanova Tsveta Chief Commercial Officer		Agios Pharmaceuticals, Inc. - AGIO	245% 3.83K to 13.23K	0	0	--	--	Show Txns Hide Txns

17-Jun-24 5:31 PM View:	13-Jun-24 Option Exercise 0	Fouse Jacqualyn A Director		Agios Pharmaceuticals, Inc. - AGIO	32% 106.97K to 140.78K	0	0	--	--	Show Txns Hide Txns

17-Jun-24 5:13 PM View:	13-Jun-24 Option Exercise 0	Capello Jeffrey D Director		Agios Pharmaceuticals, Inc. - AGIO	100% 0 to 1.98K	0	0	--	--	Show Txns Hide Txns

17-Jun-24 5:15 PM View:	13-Jun-24 Option Exercise 0	Owen Catherine E. Director		Agios Pharmaceuticals, Inc. - AGIO	100% 0 to 1.98K	0	0	--	--	Show Txns Hide Txns

Agios Pharmaceuticals, Inc. (AGIO)

Last Year

26-Nov-23 -- 25-Nov-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	($60.46K)	$44.39